Evidence map›Paper›PMID 32700225›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2021

Clinical and magnetic resonance imaging monitoring in progressive multifocal leukoencephalopathy treated with pembrolizumab: a case report.

Jakob Stögbauer, Walter Schulz-Schaeffer, Ruben Mühl-Benninghaus, Piergiorgio Lochner

Open access · hybridAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jakob StögbauerDepartment of Neurology, Saarland University, D-66421, Homburg, Saarland, Germany. Jakob.stoegbauer@web.de.ORCID 0000-0003-3311-2546
Walter Schulz-SchaefferDepartment of Neuropathology, Saarland University, D-66421, Homburg, Saarland, Germany.
Ruben Mühl-BenninghausDepartment of Neuroradiology, Saarland University, D-66421, Homburg, Saarland, Germany.
Piergiorgio LochnerDepartment of Neurology, Saarland University, D-66421, Homburg, Saarland, Germany.
Saarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukoencephalopathy, Progressive MultifocalAntibodies, Monoclonal, HumanizedHumansMagnetic Resonance ImagingAntibodies, Monoclonal, Humanizedpembrolizumab

Identifiers

PMID32700225
PMCPMC7819910
OpenAlexW3044354587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.